Codexis - Poised to Deliver on Promise of RNAi

Enzymes are the engines that drive the fundamental chemical reactions that make life possible. They are responsible for metabolism, respiration, digesting food and movement, among many other bodily functions and chemical reactions. Essentially, enzymes are the building blocks of life. When enzymes are not working properly or are missing altogether, there can be detrimental impacts to the human body. Codexis was initially built around its enzyme engineering capability based on its world-leading CodeEvolver® technology. CodeEvolver® enables the Company to tailor performance enzymes for specific applications and processes. That technology led to continual customer feedback that Codexis could solve difficult problems that couldn’t be overcome in their own labs or via chemical reactions. Today, the team is working to build out a suite of enzymes to enable an entire class of new medicines. This new, proprietary technology—Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis™—is built to support the development of ribonucleic acid interference (RNAi) therapeutics by efficiently synthesizing short inhibitory RNA (siRNA) oligonucleotide sequences. Find out more: https://www.codexis.com/ _________________________________________________________________________________________________ TBD Media is an international purpose driven media group that helps companies, organisations and governments tell their brand stories in a direct and human way. Combining over 30 years of experience in marketing, content creation, video production and publishing, our senior team have been providing thought-provoking content since 2015. Learn more about our projects and campaigns on: https://www.tbdmediagroup.com/ Follow us on social media! Facebook: @TBDMedia Twitter: @TBD_Media LinkedIn: TBD Media Group Instagram: @tbdmediagroup